Truist Financial Corp Sorrento Therapeutics, Inc. Transaction History

Truist Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$1.24 - $2.33 $28,086 - $52,774	22,650 New	22,650 $45,000
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $60,454 - $93,997	-13,001 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$7.41 - $10.99 $175,617 - $260,463	-23,700 Reduced 64.58%	13,001 $99,000
Q2 2021 Aug 16, 2021	BUY	$6.35 - $10.0 $29,210 - $46,000	4,600 Added 14.33%	36,701 $355,000
Q1 2021 May 17, 2021	SELL	$7.03 - $16.51 $34,411 - $80,816	-4,895 Reduced 13.23%	32,101 $265,000
Q4 2020 Nov 19, 2021	SELL	$5.76 - $11.95 $103,703 - $215,147	-18,004 Reduced 32.73%	36,996 $253,000
Q4 2020 Feb 18, 2021	BUY	$5.76 - $11.95 $79,799 - $165,555	13,854 Added 33.67%	55,000 $376,000
Q3 2020 Nov 13, 2020	SELL	$6.17 - $18.82 $57,226 - $174,555	-9,275 Reduced 18.4%	41,146 $459,000
Q2 2020 Aug 14, 2020	BUY	$1.73 - $6.76 $87,228 - $340,845	50,421 New	50,421 $317,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.